Hook & thesis
Nebius (NBIS) cratered after the 11/13/2026 print despite posting a blowout quarter: revenue of $980.8M (571% year-over-year) and adjusted EBITDA of $465.8M. The market punished guidance cuts, raised capex needs and deployment delays. That selloff creates a two-part buying case: 1) the company is already showing asset-light contract economics and strong margin expansion, and 2) a sizable portion of 2027 capex is effectively pre-funded via customer prepayments and asset-backed financing, lowering execution risk relative to headline capex numbers.
This is a disciplined, high-conviction long trade on the post-earnings capitulation. Market narratives are focused on mega capex and near-term delays; we focus on unit economics and funded-capacity. If Nebius can convert booked customer commitments into deployed capacity at improving pricing, the stock should re-rate well above current levels. If it cannot, this is a fast move to the stop.
What Nebius does and why investors should care
Nebius is an AI-centric cloud platform and GPU-as-a-service provider that sells large-scale compute capacity to generative AI builders. Its stack includes Nebius AI (GPU clusters, cloud services and developer tools) and complementary businesses - Toloka AI (data services), TripleTen (reskilling/edtech) and Avride (autonomous driving). The company is positioned as a core infrastructure provider for an industry where demand is exploding - that explains the 643% growth reported for the AI Cloud segment in Q3.
Why it matters: Nebius is selling high-ticket, long-duration compute contracts (management disclosed customer commitments > $12B and contract pricing above $25M per MW in the quarter). Those recurring, enterprise-style deals can produce outsized cash conversion when pricing and utilization are high. Management also said customer prepayments now cover >100% of new capacity capex, meaning incremental capacity can be built with limited equity dilution if asset-backed financing holds.
| Metric | Reported |
|---|---|
| Q3 Revenue | $980.8M |
| Q3 Adjusted EBITDA | $465.8M |
| YoY Revenue Growth (Q3) | 571% |
| Market Cap | $31.48B |
| 52-week range | $73.52 - $299.86 |
Evidence backing the buy case
- Economics are improving materially. Management disclosed Q3 adjusted EBITDA of $465.8M on $980.8M revenue - a 47.5% adjusted EBITDA margin. That’s not startup burn; that’s high-margin, high-return revenue at scale.
- Demand is real and granular. The company reported over $12B of customer commitments and contract pricing north of $25M/MW in the quarter, showing buyers are willing to lock-in capacity at meaningful prices.
- Prepayments de-risk capex. Management expects 75-85% of 2027 capex to be funded via customer prepayments and asset-backed financing; they said customer prepayments now exceed 100% of new capacity capex. That shifts the capex risk from equity markets to contract performance and lenders.
- Valuation dislocation. After the drop the stock trades at an implied ~3x sales multiple (reported commentary) versus historical tech/cloud multiples and versus the narrative of 22x sales some investors were using as a reference before the selloff. With $3.0-3.2B guidance for 2026 and $12-13B target for 2027, the market has heavily discounted growth ahead of visible demand conversion.
How the market priced the report and what went wrong
Investors punished Nebius for three things in the print on 11/13/2026: lowered 2026 guidance ($3.0-3.2B), a sharp increase in 2027 capex guidance ($40-45B), and delays in third-party data center deployments. These are real execution notes, but they are operational/timing issues rather than flailing demand. The company beat Q3 top-line and EBITDA, but the market sold sizeably because the cadence of capacity delivery matters for cash flow timing and the absolute capex number looks scary on headlines.
Valuation framing
Nebius currently sits at a market cap of roughly $31.48B. Management’s mid-point 2026 revenue guide ($3.1B) implies the stock is trading at ~10x 2026 revenue, but the Q3 narrative and street commentary have implied a lower effective multiple (the market commentary cited an ~3x sales figure factoring in 2027 expectations and rapid revenue ramps). In any case, you are buying a company with demonstrated ability to monetize AI compute at enterprise contract levels and expand margins rapidly once capacity is live.
Compare qualitatively: legacy cloud providers trade at revenue multiples reflecting durable margins and diversified businesses. Nebius is higher-risk but potentially higher-reward: if Nebius executes on capacity and converts booked commitments, the growth profile could justify a big re-rating. If not, the stock could remain under pressure.
Catalysts (what will make this trade work)
- Faster-than-expected catch-up on delayed data center deployments or acceleration of third-party partner builds - turns headline capex into visible revenue.
- Monthly/quarterly disclosure of customer prepayments and percent of new capacity covered - continued confirmation that >100% of new capacity is pre-funded.
- Contract wins and expansion announcements with large enterprise customers that convert the $12B+ commitments into scheduled deployments.
- Improving macro funding conditions or asset-backed financing availability that keeps the incremental cash cost of growth manageable.
Trade plan - actionable entry, stop and target
Entry: Buy at $115.81.
Stop loss: $90.00.
Target: $220.00.
Horizon: long term (180 trading days). The initial thesis is that, over the next ~180 trading days, Nebius can either start turning committed customer dollars into delivered capacity or at minimum show measurable progress that narrows the gap between headline capex and funded capacity. The target of $220 assumes partial de-risking and a multiple re-rating as revenue ramps and adjusted EBITDA stay strong; the stop at $90 protects against execution failure or a sustained contraction in contract pricing.
Sizing & rules of engagement
This is a high-volatility, high-reward name. Consider sizing the position modestly (e.g., 1-3% of liquid equity allocation) and layer in half at entry with a second tranche on pullback toward $100 if you want broader exposure. Move stops to breakeven after a 25-30% unrealized gain and tighten to 10% under new support if the trade reaches the target zone.
Risk checklist - what can go wrong (and the counterargument)
- Macro funding and credit squeeze: Nebius’s footprint requires massive capital. If asset-backed financing dries up or borrowing costs spike further, the company might be forced into dilutive financing or delay builds longer. Counterargument: management said 75-85% of 2027 capex is expected to be funded by prepayments and asset-backed finance; that structural protection lowers equity funding reliance.
- Deployment delays & partner execution: Third-party data center partners missing timelines would push revenue out beyond the 180-day trade horizon and compress multiples. This is precisely what spooked the market in the latest print.
- Customer concentration / contract risk: Big commitments can look good on paper but are vulnerable to renegotiation or attrition if customers internalize more compute (Microsoft, for example, is shifting more workloads in-house). Counterargument: Nebius reported large, above-$25M/MW contract pricing and customer prepayments that align incentives for both sides; still, concentration is a real risk.
- Regulatory & policy risk: Changes in data center permitting or state-level policy (for example, energy rules) could increase capex timelines and costs.
- Valuation multiple compression: Even with strong revenue growth, multiple contraction across the cloud/neocloud complex could keep the stock depressed despite improving fundamentals.
Counterargument to the buy case: The market is pricing in the operational reality that Nebius needs tens of billions of dollars to reach the revenue targets it has articulated for 2027. If management cannot demonstrate reliable, repeatable deployment timelines or if customers start bringing capacity in-house at scale, the valuation could crater. That scenario is plausible and would invalidate the long premise.
What would change my mind
I would materially raise the conviction if, within two quarters, management: delivers a clear timetable converting at least 30-40% of the $12B in commitments into deployed capacity; shows continued >40% adjusted EBITDA margins as capacity turns live; and provides quarterly reporting that confirms customer prepayments continue to exceed incremental capacity capex. Conversely, I would cut the position if customer prepayments fell materially below funding needs, if material contract cancellations emerged, or if asset-backed financing evaporated and forced equity dilution above acceptable levels.
Bottom line
Nebius is the kind of high-variance, high-conviction trade that rewards disciplined entry and strict risk management. The core bull case is simple: demand and pricing are proven; economics are impressive at scale; and a large portion of capex is pre-funded. The bear case is execution and financing risk. For traders willing to accept volatility and size the position conservatively, buying the bloodbath at $115.81 with a $90 stop and a $220 target over 180 trading days is a defensible, data-driven contrarian trade.